Global Live Attenuated Vaccines Market Research Report 2026(Status and Outlook)

May 2026 | 134 pages | ID: G804D2A5FE9FEN
Bosson Research

Abstracts

An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live"). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by "killing" the virus (inactivated vaccine).The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The global Live Attenuated Vaccines market size was estimated at USD 29870.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.10% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Live Attenuated Vaccines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Live Attenuated Vaccines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Live Attenuated Vaccines market.

Global Live Attenuated Vaccines Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• GlaxoSmithKline
• Merck
• Pfizer
• Astellas Pharma
• Johnson & Johnson
• CSL
• Sanofi
• Serum Institute Of India

Market Segmentation (by Type)

• Bacterial
• Viral

Market Segmentation (by Application)

• Hospitals
• Clinics
• Research Institutes
• Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Live Attenuated Vaccines Market

Overview of the regional outlook of the Live Attenuated Vaccines Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Live Attenuated Vaccines Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Live Attenuated Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Live Attenuated Vaccines
1.2 Key Market Segments
  1.2.1 Live Attenuated Vaccines Segment by Type
  1.2.2 Live Attenuated Vaccines Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 LIVE ATTENUATED VACCINES MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Live Attenuated Vaccines Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Live Attenuated Vaccines Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 LIVE ATTENUATED VACCINES MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Live Attenuated Vaccines Product Life Cycle
3.3 Global Live Attenuated Vaccines Sales by Manufacturers (2020-2025)
3.4 Global Live Attenuated Vaccines Revenue Market Share by Manufacturers (2020-2025)
3.5 Live Attenuated Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Live Attenuated Vaccines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Live Attenuated Vaccines Market Competitive Situation and Trends
  3.8.1 Live Attenuated Vaccines Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Live Attenuated Vaccines Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 LIVE ATTENUATED VACCINES INDUSTRY CHAIN ANALYSIS

4.1 Live Attenuated Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF LIVE ATTENUATED VACCINES MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Live Attenuated Vaccines Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Live Attenuated Vaccines Market
5.7 ESG Ratings of Leading Companies

6 LIVE ATTENUATED VACCINES MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Live Attenuated Vaccines Sales Market Share by Type (2020-2025)
6.3 Global Live Attenuated Vaccines Market Size by Type (2020-2025)
6.4 Global Live Attenuated Vaccines Price by Type (2020-2025)

7 LIVE ATTENUATED VACCINES MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Live Attenuated Vaccines Market Sales by Application (2020-2025)
7.3 Global Live Attenuated Vaccines Market Size (M USD) by Application (2020-2025)
7.4 Global Live Attenuated Vaccines Sales Growth Rate by Application (2020-2025)

8 LIVE ATTENUATED VACCINES MARKET SALES BY REGION

8.1 Global Live Attenuated Vaccines Sales by Region
  8.1.1 Global Live Attenuated Vaccines Sales by Region
  8.1.2 Global Live Attenuated Vaccines Sales Market Share by Region
8.2 Global Live Attenuated Vaccines Market Size by Region
  8.2.1 Global Live Attenuated Vaccines Market Size by Region
  8.2.2 Global Live Attenuated Vaccines Market Size by Region
8.3 North America
  8.3.1 North America Live Attenuated Vaccines Sales by Country
  8.3.2 North America Live Attenuated Vaccines Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Live Attenuated Vaccines Sales by Country
  8.4.2 Europe Live Attenuated Vaccines Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Live Attenuated Vaccines Sales by Region
  8.5.2 Asia Pacific Live Attenuated Vaccines Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Live Attenuated Vaccines Sales by Country
  8.6.2 South America Live Attenuated Vaccines Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Live Attenuated Vaccines Sales by Region
  8.7.2 Middle East and Africa Live Attenuated Vaccines Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 LIVE ATTENUATED VACCINES MARKET PRODUCTION BY REGION

9.1 Global Production of Live Attenuated Vaccines by Region(2020-2025)
9.2 Global Live Attenuated Vaccines Revenue Market Share by Region (2020-2025)
9.3 Global Live Attenuated Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Live Attenuated Vaccines Production
  9.4.1 North America Live Attenuated Vaccines Production Growth Rate (2020-2025)
  9.4.2 North America Live Attenuated Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Live Attenuated Vaccines Production
  9.5.1 Europe Live Attenuated Vaccines Production Growth Rate (2020-2025)
  9.5.2 Europe Live Attenuated Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Live Attenuated Vaccines Production (2020-2025)
  9.6.1 Japan Live Attenuated Vaccines Production Growth Rate (2020-2025)
  9.6.2 Japan Live Attenuated Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Live Attenuated Vaccines Production (2020-2025)
  9.7.1 China Live Attenuated Vaccines Production Growth Rate (2020-2025)
  9.7.2 China Live Attenuated Vaccines Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 GlaxoSmithKline
  10.1.1 GlaxoSmithKline Basic Information
  10.1.2 GlaxoSmithKline Live Attenuated Vaccines Product Overview
  10.1.3 GlaxoSmithKline Live Attenuated Vaccines Product Market Performance
  10.1.4 GlaxoSmithKline Business Overview
  10.1.5 GlaxoSmithKline SWOT Analysis
  10.1.6 GlaxoSmithKline Recent Developments
10.2 Merck
  10.2.1 Merck Basic Information
  10.2.2 Merck Live Attenuated Vaccines Product Overview
  10.2.3 Merck Live Attenuated Vaccines Product Market Performance
  10.2.4 Merck Business Overview
  10.2.5 Merck SWOT Analysis
  10.2.6 Merck Recent Developments
10.3 Pfizer
  10.3.1 Pfizer Basic Information
  10.3.2 Pfizer Live Attenuated Vaccines Product Overview
  10.3.3 Pfizer Live Attenuated Vaccines Product Market Performance
  10.3.4 Pfizer Business Overview
  10.3.5 Pfizer SWOT Analysis
  10.3.6 Pfizer Recent Developments
10.4 Astellas Pharma
  10.4.1 Astellas Pharma Basic Information
  10.4.2 Astellas Pharma Live Attenuated Vaccines Product Overview
  10.4.3 Astellas Pharma Live Attenuated Vaccines Product Market Performance
  10.4.4 Astellas Pharma Business Overview
  10.4.5 Astellas Pharma Recent Developments
10.5 Johnson and Johnson
  10.5.1 Johnson and Johnson Basic Information
  10.5.2 Johnson and Johnson Live Attenuated Vaccines Product Overview
  10.5.3 Johnson and Johnson Live Attenuated Vaccines Product Market Performance
  10.5.4 Johnson and Johnson Business Overview
  10.5.5 Johnson and Johnson Recent Developments
10.6 CSL
  10.6.1 CSL Basic Information
  10.6.2 CSL Live Attenuated Vaccines Product Overview
  10.6.3 CSL Live Attenuated Vaccines Product Market Performance
  10.6.4 CSL Business Overview
  10.6.5 CSL Recent Developments
10.7 Sanofi
  10.7.1 Sanofi Basic Information
  10.7.2 Sanofi Live Attenuated Vaccines Product Overview
  10.7.3 Sanofi Live Attenuated Vaccines Product Market Performance
  10.7.4 Sanofi Business Overview
  10.7.5 Sanofi Recent Developments
10.8 Serum Institute Of India
  10.8.1 Serum Institute Of India Basic Information
  10.8.2 Serum Institute Of India Live Attenuated Vaccines Product Overview
  10.8.3 Serum Institute Of India Live Attenuated Vaccines Product Market Performance
  10.8.4 Serum Institute Of India Business Overview
  10.8.5 Serum Institute Of India Recent Developments

11 LIVE ATTENUATED VACCINES MARKET FORECAST BY REGION

11.1 Global Live Attenuated Vaccines Market Size Forecast
11.2 Global Live Attenuated Vaccines Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Live Attenuated Vaccines Market Size Forecast by Country
  11.2.3 Asia Pacific Live Attenuated Vaccines Market Size Forecast by Region
  11.2.4 South America Live Attenuated Vaccines Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Live Attenuated Vaccines by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Live Attenuated Vaccines Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Live Attenuated Vaccines by Type (2026-2035)
  12.1.2 Global Live Attenuated Vaccines Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Live Attenuated Vaccines by Type (2026-2035)
12.2 Global Live Attenuated Vaccines Market Forecast by Application (2026-2035)
  12.2.1 Global Live Attenuated Vaccines Sales (K MT) Forecast by Application
  12.2.2 Global Live Attenuated Vaccines Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Live Attenuated Vaccines Market Size by Type (M USD)
Table 4. Global Live Attenuated Vaccines Market Size by Application
Table 5. Live Attenuated Vaccines Market Size Comparison by Region (M USD)
Table 6. Global Live Attenuated Vaccines Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Live Attenuated Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Live Attenuated Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Live Attenuated Vaccines Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Attenuated Vaccines as of 2025)
Table 11. Global Market Live Attenuated Vaccines Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Live Attenuated Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Live Attenuated Vaccines Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Live Attenuated Vaccines Sales by Type (K MT)
Table 27. Global Live Attenuated Vaccines Market Size by Type (M USD)
Table 28. Global Live Attenuated Vaccines Sales (K MT) by Type (2020-2025)
Table 29. Global Live Attenuated Vaccines Sales Market Share by Type (2020-2025)
Table 30. Global Live Attenuated Vaccines Market Size (M USD) by Type (2020-2025)
Table 31. Global Live Attenuated Vaccines Market Share by Type (2020-2025)
Table 32. Global Live Attenuated Vaccines Price (USD/KG) by Type (2020-2025)
Table 33. Global Live Attenuated Vaccines Sales (K MT) by Application
Table 34. Global Live Attenuated Vaccines Market Size by Application
Table 35. Global Live Attenuated Vaccines Sales by Application (2020-2025) & (K MT)
Table 36. Global Live Attenuated Vaccines Sales Market Share by Application (2020-2025)
Table 37. Global Live Attenuated Vaccines Market Size by Application (2020-2025) & (M USD)
Table 38. Global Live Attenuated Vaccines Market Share by Application (2020-2025)
Table 39. Global Live Attenuated Vaccines Sales Growth Rate by Application (2020-2025)
Table 40. Global Live Attenuated Vaccines Sales by Region (2020-2025) & (K MT)
Table 41. Global Live Attenuated Vaccines Sales Market Share by Region (2020-2025)
Table 42. Global Live Attenuated Vaccines Market Size by Region (2020-2025) & (M USD)
Table 43. Global Live Attenuated Vaccines Market Size by Region (2020-2025)
Table 44. North America Live Attenuated Vaccines Sales by Country (2020-2025) & (K MT)
Table 45. North America Live Attenuated Vaccines Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Live Attenuated Vaccines Sales by Country (2020-2025) & (K MT)
Table 47. Europe Live Attenuated Vaccines Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Live Attenuated Vaccines Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Live Attenuated Vaccines Market Size by Region (2020-2025) & (M USD)
Table 50. South America Live Attenuated Vaccines Sales by Country (2020-2025) & (K MT)
Table 51. South America Live Attenuated Vaccines Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Live Attenuated Vaccines Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Live Attenuated Vaccines Market Size by Region (2020-2025) & (M USD)
Table 54. Global Live Attenuated Vaccines Production (K MT) by Region(2020-2025)
Table 55. Global Live Attenuated Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Live Attenuated Vaccines Revenue Market Share by Region (2020-2025)
Table 57. Global Live Attenuated Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Live Attenuated Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Live Attenuated Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Live Attenuated Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Live Attenuated Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. GlaxoSmithKline Basic Information
Table 63. GlaxoSmithKline Live Attenuated Vaccines Product Overview
Table 64. GlaxoSmithKline Live Attenuated Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline SWOT Analysis
Table 67. GlaxoSmithKline Recent Developments
Table 68. Merck Basic Information
Table 69. Merck Live Attenuated Vaccines Product Overview
Table 70. Merck Live Attenuated Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Merck Business Overview
Table 72. Merck SWOT Analysis
Table 73. Merck Recent Developments
Table 74. Pfizer Basic Information
Table 75. Pfizer Live Attenuated Vaccines Product Overview
Table 76. Pfizer Live Attenuated Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Pfizer Business Overview
Table 78. Pfizer SWOT Analysis
Table 79. Pfizer Recent Developments
Table 80. Astellas Pharma Basic Information
Table 81. Astellas Pharma Live Attenuated Vaccines Product Overview
Table 82. Astellas Pharma Live Attenuated Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Astellas Pharma Business Overview
Table 84. Astellas Pharma Recent Developments
Table 85. Johnson and Johnson Basic Information
Table 86. Johnson and Johnson Live Attenuated Vaccines Product Overview
Table 87. Johnson and Johnson Live Attenuated Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Johnson and Johnson Business Overview
Table 89. Johnson and Johnson Recent Developments
Table 90. CSL Basic Information
Table 91. CSL Live Attenuated Vaccines Product Overview
Table 92. CSL Live Attenuated Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. CSL Business Overview
Table 94. CSL Recent Developments
Table 95. Sanofi Basic Information
Table 96. Sanofi Live Attenuated Vaccines Product Overview
Table 97. Sanofi Live Attenuated Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Sanofi Business Overview
Table 99. Sanofi Recent Developments
Table 100. Serum Institute Of India Basic Information
Table 101. Serum Institute Of India Live Attenuated Vaccines Product Overview
Table 102. Serum Institute Of India Live Attenuated Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Serum Institute Of India Business Overview
Table 104. Serum Institute Of India Recent Developments
Table 105. Global Live Attenuated Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 106. Global Live Attenuated Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America Live Attenuated Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 108. North America Live Attenuated Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe Live Attenuated Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 110. Europe Live Attenuated Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific Live Attenuated Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 112. Asia Pacific Live Attenuated Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America Live Attenuated Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 114. South America Live Attenuated Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa Live Attenuated Vaccines Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa Live Attenuated Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global Live Attenuated Vaccines Sales Forecast by Type (2026-2035) & (K MT)
Table 118. Global Live Attenuated Vaccines Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global Live Attenuated Vaccines Price Forecast by Type (2026-2035) & (USD/KG)
Table 120. Global Live Attenuated Vaccines Sales (K MT) Forecast by Application (2026-2035)
Table 121. Global Live Attenuated Vaccines Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Live Attenuated Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Live Attenuated Vaccines Market Size (M USD), 2025-2035
Figure 5. Global Live Attenuated Vaccines Market Size (M USD) (2020-2035)
Figure 6. Global Live Attenuated Vaccines Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Live Attenuated Vaccines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Live Attenuated Vaccines Product Life Cycle
Figure 13. Live Attenuated Vaccines Sales Share by Manufacturers in 2025
Figure 14. Global Live Attenuated Vaccines Revenue Share by Manufacturers in 2025
Figure 15. Live Attenuated Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Live Attenuated Vaccines Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Live Attenuated Vaccines Revenue in 2025
Figure 18. Industry Chain Map of Live Attenuated Vaccines
Figure 19. Global Live Attenuated Vaccines Market PEST Analysis
Figure 20. Global Live Attenuated Vaccines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Live Attenuated Vaccines Market Share by Type
Figure 27. Sales Market Share of Live Attenuated Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of Live Attenuated Vaccines by Type in 2025
Figure 29. Market Share of Live Attenuated Vaccines by Type (2020-2025)
Figure 30. Market Share of Live Attenuated Vaccines by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Live Attenuated Vaccines Market Share by Application
Figure 33. Global Live Attenuated Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global Live Attenuated Vaccines Sales Market Share by Application in 2025
Figure 35. Global Live Attenuated Vaccines Market Share by Application (2020-2025)
Figure 36. Global Live Attenuated Vaccines Market Share by Application in 2025
Figure 37. Global Live Attenuated Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global Live Attenuated Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global Live Attenuated Vaccines Market Size by Region (2020-2025)
Figure 40. North America Live Attenuated Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Live Attenuated Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Live Attenuated Vaccines Sales Market Share by Country in 2024
Figure 43. North America Live Attenuated Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Live Attenuated Vaccines Market Size by Country in 2024
Figure 45. U.S. Live Attenuated Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Live Attenuated Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Live Attenuated Vaccines Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Live Attenuated Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Live Attenuated Vaccines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Live Attenuated Vaccines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Live Attenuated Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Live Attenuated Vaccines Sales Market Share by Country in 2024
Figure 53. Europe Live Attenuated Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Live Attenuated Vaccines Market Size by Country in 2024
Figure 55. Germany Live Attenuated Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Live Attenuated Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Live Attenuated Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Live Attenuated Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Live Attenuated Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Live Attenuated Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Live Attenuated Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Live Attenuated Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Live Attenuated Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Live Attenuated Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Live Attenuated Vaccines Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Live Attenuated Vaccines Sales Market Share by Region in 2024
Figure 67. Asia Pacific Live Attenuated Vaccines Market Size by Region in 2024
Figure 68. China Live Attenuated Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Live Attenuated Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Live Attenuated Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Live Attenuated Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Live Attenuated Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Live Attenuated Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Live Attenuated Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Live Attenuated Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Live Attenuated Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Live Attenuated Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Live Attenuated Vaccines Sales and Growth Rate (K MT)
Figure 79. South America Live Attenuated Vaccines Sales Market Share by Country in 2024
Figure 80. South America Live Attenuated Vaccines Market Size and Growth Rate (M USD)
Figure 81. South America Live Attenuated Vaccines Market Size by Country in 2024
Figure 82. Brazil Live Attenuated Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Live Attenuated Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Live Attenuated Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Live Attenuated Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Live Attenuated Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Live Attenuated Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Live Attenuated Vaccines Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Live Attenuated Vaccines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Live Attenuated Vaccines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Live Attenuated Vaccines Market Size by Region in 2024
Figure 92. Saudi Arabia Live Attenuated Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Live Attenuated Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Live Attenuated Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Live Attenuated Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Live Attenuated Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Live Attenuated Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Live Attenuated Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Live Attenuated Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Live Attenuated Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Live Attenuated Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Live Attenuated Vaccines Production Market Share by Region (2020-2025)
Figure 103. North America Live Attenuated Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Live Attenuated Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Live Attenuated Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 106. China Live Attenuated Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Live Attenuated Vaccines Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Live Attenuated Vaccines Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Live Attenuated Vaccines Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Live Attenuated Vaccines Market Share Forecast by Type (2026-2035)
Figure 111. Global Live Attenuated Vaccines Sales Forecast by Application (2026-2035)
Figure 112. Global Live Attenuated Vaccines Market Share Forecast by Application (2026-2035)